MTS Medication Technologies to Present at the AEA Micro Cap Financial Conference

  
    
  
  
    
      MTS Medication Technologies (AMEX:MPP) today announced it will 
      present at the AeA Micro Cap Financial Conference on Monday, May 5, 2008 
      in Monterey, California. The AeA Micro Cap Financial Conference provides 
      AeA members with an environment in which to showcase their public 
      companies to key technology investors. AeA is a nationwide trade 
      organization that represents all segments of the technology industry.
    
    
      MTS will make its presentation and then will be available to meet with 
      investors in separate breakout meetings.
    
    
      About the Company
    
    
      Founded in 1984, MTS Medication Technologies (www.mts-mt.com) 
      is an international provider of medication compliance packaging systems 
      designed to improve medication dispensing and administration. MTS 
      manufactures automated packaging machines and related consumables for 
      prescription medications and nutritional supplements. The Company serves 
      more than 8,000 pharmacies worldwide.
    
    
      This press release contains forward-looking information made pursuant 
      to the safe harbor provisions of the Private Securities Litigation 
      Reform Act of 1995. These forward-looking statements may be 
      affected by certain risks and uncertainties described in the Company’s 
      filings with the Securities and Exchange Commission (SEC) and actual 
      results could differ materially from those set forth in forward-looking 
      statements. Statements contained herein that are not historical 
      facts are forward-looking statements and may include, but are not 
      limited to, projections of revenue, income or losses, the value of 
      contracts, capital expenditures, plans for future operations, the 
      elimination of losses under certain programs, financing needs or plans, 
      compliance with financial covenants in loan agreements, plans for sale 
      of assets or businesses, plans relating to products or services of the 
      Company, assessments of materiality, predictions of future events and 
      the effects of pending and possible litigation, as well as assumptions 
      relating to the foregoing. Other factors that could affect such 
      differences include, but are not limited to, unanticipated increases in 
      operating costs, labor disputes, capital requirements, increases in 
      borrowing costs, product demand, pricing, market acceptance, 
      intellectual property rights and litigation, risks in product and 
      technology development and other risk factors detailed in the Company’s 
      SEC filings. All statements regarding the marketing program 
      resulting in increased sales are forward looking statements. Readers 
      are cautioned not to place undue reliance on any forward-looking 
      statements. The Company undertakes no obligation to publicly 
      release the result of any revisions of these forward-looking statements 
      that may be made to reflect events or circumstances after the date 
      hereof or to reflect the occurrence of unexpected events.